News
ICU Medical, Investor Conferences
Digest more
TipRanks on MSN6d
Piper Sandler bullish on ICU Medical, initiates with an Overweight
As previously reported, Piper Sandler analyst Jason Bednar initiated coverage of ICU Medical (ICUI) with an Overweight rating and $145 price target The infusion pump market faced regulatory and ...
ICU Medical starts off 2022 with the considerable task of integrating Smiths Medical. Operating synergies should provide a path to ICUI trading at 3.35x-3.5x sales in FY'24.
ICU Medical now looks to have a multiyear road to get that new business unit up to speed. In the second quarter of 2022, management cut its full-year adjusted EPS and EBITDA guidance range by ...
SAN CLEMENTE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial ...
ICU Medical shares do look undervalued, but valuation of slow-growing small-cap medical device companies is tricky, and I'd prefer to see more evidence of stabilization and reacceleration.
ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors ...
In trading on Wednesday, shares of ICU Medical, Inc. (NASD: ICUI) crossed above their 200 day moving average of $66.17, changing hands as high as $66.20 per share.
What happenedShares of ICU Medical (NASDAQ: ICUI), a medical device company specializing in intravenous treatment solutions, were on the move today following the announcement of a cash and stock ...
ICU Medical Inc. ICUI 0.55% agreed to buy Pfizer Inc.’s infusion-systems business in a $1 billion cash-and-stock deal, giving the California medical-device maker a larger footprint in the global ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback